Market Alert: Strong Nuclear Tensions in South Asia Assessing the Fallout on Global Equity Markets
Highlights:
Consilium Cracks NZ$100 Million Milestone
Consilium’s KiwiWRAP KiwiSaver Scheme, managed by Consilium NZ Limited (CNL), has achieved a significant milestone, surpassing NZ$100 million in funds under management (FUM). This achievement has been driven by the transfer of large balances from other schemes, reflecting the growing confidence in KiwiWRAP’s tailored investment approach.
Impressive Growth in Client Balances
Over the past year, the average portfolio balance within KiwiWRAP has grown from NZ$150,000 to NZ$177,000, showcasing a strong trend among investors seeking more personalized advice. Consilium’s Managing Director, Scott Alman, highlighted the scheme's success in attracting high-balance clients, with the number of accounts exceeding NZ$500,000 tripling and several surpassing the NZ$1 million mark.
“Our KiwiWRAP Scheme’s rapid growth is a testament to the exceptional work of advisers and the returns investors are achieving,” Alman stated. He emphasized that the scheme’s total FUM has doubled over the past year, and forecasts indicate continued robust growth.
Tailored Investment Choices Drive Success
KiwiWRAP stands out in the market by offering over 400 investment options, the most diverse range among KiwiSaver schemes. This advice-led scheme, available exclusively through accredited financial advisers, allows investors to tailor their portfolios to meet their specific needs.
Alman pointed out that KiwiWRAP's unique position in the market has not only fueled its growth but has also enhanced how advisers engage with clients. “Higher-balance investors are increasingly seeking tailored advice on their KiwiSaver investments, and our scheme provides them with the flexibility and choice they desire,” he said.
As average KiwiSaver balances continue to grow, Consilium anticipates even greater opportunities for advisers to deliver tailored investment advice on a broader scale.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 24, 2025
Apr 24, 2025
Apr 23, 2025
Apr 23, 2025
Apr 22, 2025
Apr 22, 2025
Apr 17, 2025
Apr 17, 2025
Apr 16, 2025
Apr 16, 2025
The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.